Ongoing breakthroughs in cancer care involve personalized medicine, we are often informed. Because every malignancy is unique in terms of its genetics and genomics, one size (or protocol) cannot fit all.
A diagnosis of multiple myeloma, cancer of the plasma cells, motivated Dr. C. Anthony Blau of the University of Washington to come up with an innovative approach to his disease. He combined his research in hematology, his physician wife’s clinical expertise and crowdsourcing to develop an individualized treatment plan.
As a cancer patient whose life has been extended by an experimental drug, I was curious about Dr. Blau’s approach. By what methods can medical practices be tailor-made? And how do scientists find the ways and means to extend analyses of individual cases to a significant aggregate of patients?
No comments:
Post a Comment